Analyst Ratings For Genocea Biosciences (NASDAQ:GNCA)
Today, Cowen and Company reiterated its Outperform rating on Genocea Biosciences (NASDAQ:GNCA) with a price target of $40.00.
There are 4 buy ratings on the stock.
The current consensus rating on Genocea Biosciences (NASDAQ:GNCA) is Buy (Score: 3.00) with a consensus target price of $21.75 per share, a potential 273.07% upside.
Some recent analyst ratings include
- 7/25/2017-Cowen and Company Reiterated Rating of Outperform.
- 7/25/2017-Piper Jaffray Companies Reiterated Rating of Overweight.
- 7/24/2017-Needham & Company LLC Upgrade from a “Hold ” rating to a ” Buy” rating.
- 1/23/2017-FBR & Co Reiterated Rating of Outperform.
Recent Insider Trading Activity For Genocea Biosciences (NASDAQ:GNCA)
Genocea Biosciences (NASDAQ:GNCA) has insider ownership of 6.70% and institutional ownership of 54.23%.
- On 7/24/2017 Jonathan Poole, CFO, sold 45,000 with an average share price of $6.00 per share and the total transaction amounting to $270,000.00. View SEC Filing
- On 11/8/2016 Eric S. Hoffman, Insider, bought 7,000 with an average share price of $3.49 per share and the total transaction amounting to $24,430.00. View SEC Filing
- On 11/7/2016 Jonathan Poole, CFO, bought 7,000 with an average share price of $3.34 per share and the total transaction amounting to $23,380.00. View SEC Filing
- On 11/7/2016 William D. Clark, Insider, bought 2,800 with an average share price of $3.49 per share and the total transaction amounting to $9,772.00. View SEC Filing
- On 5/9/2016 Jonathan Poole, CFO, bought 4,000 with an average share price of $3.88 per share and the total transaction amounting to $15,520.00. View SEC Filing
- On 12/16/2015 William D Clark, CEO, bought 3,800 with an average share price of $6.45 per share and the total transaction amounting to $24,510.00. View SEC Filing
- On 9/1/2015 Jessica Baker Flechtner, VP, sold 2,229 with an average share price of $11.35 per share and the total transaction amounting to $25,299.15. View SEC Filing
Recent Trading Activity for Genocea Biosciences (NASDAQ:GNCA)
Shares of Genocea Biosciences closed the previous trading session at 6.35 up +0.52 8.92% with 8,217,375 shares trading hands.